Screener
AN2 Therapeutics, Inc. ANTX Q4 2025 Annual earnings
Reported March 17, 2026 · Before market open
EPS-$0.29Miss by $0.05
EPS estimate-$0.24
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$0.20
Versus estimates
Diluted EPS
FAQ
- When did AN2 Therapeutics, Inc. report Q4 2025 earnings?
- AN2 Therapeutics, Inc. (ANTX) reported Q4 2025 earnings on March 17, 2026 before market open.
- What were AN2 Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- AN2 Therapeutics, Inc. reported eps of $-0.29 for Q4 2025.
- Did AN2 Therapeutics, Inc. beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.24 by $0.05.
- How did AN2 Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 16.0% from $-0.25.
- Where can I find AN2 Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-110681) and the 10-K periodic report (0001193125-26-110693) directly on SEC EDGAR. The filing index links above go to sec.gov.
